An active metabolite of cilostazol
Related Products
Parent Compound(s)
15035Cilostazol
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

3,4-dehydro Cilostazol

Item No. 35075

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-2(1H)-quinolinone
CAS Number
73963-62-9
Synonyms
  • OPC 13015
Molecular Formula
C20H25N5O2
Formula Weight
367.4
Purity
≥90%
Formulation (Request formulation change)
A solid
Solubility(Learn about Variance in Solubility)
DMSO: Soluble
SMILES
O=C1C=CC2=C(N1)C=CC(OCCCCC3=NN=NN3C4CCCCC4)=C2
InChi Code
InChI=1S/C20H25N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h9-12,14,16H,1-8,13H2,(H,21,26)
InChi Key
GHALECSGOJQOHW-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $44

    Add

    5 mg

    $174

    Add

    10 mg

    $326

    Add

    25 mg

    $758

    Add
    Product Description

    3,4-dehydro Cilostazol is an active metabolite of the PDE3A inhibitor cilostazol (Item No. 15035).1,2 It is formed from cilostazol by the cytochrome P450 (CYP) isoforms CYP3A4 and CYP2C19.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Suri, A., Forbes, W.P., and Bramer, S.L. Effects of CYP3A inhibition on the metabolism of cilostazol. Clin. Pharmacokinet. 37(Suppl 2), 61-68 (1999).

    2. Liu, Y., Shakur, Y., Yoshitake, M., et al. Cilostazol (pletal): A dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake. Cardiovasc. Drug Rev. 19(4), 369-386 (2001).